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Introduction
Chronic kidney disease (CKD) has joined a list of
other ﬁnancially-incentivised quality indicators for
UK general practice contained within the Quality
and Outcomes Framework (QOF).1 The QOF CKD
indicators expect practices to identify people with
CKD and to control their blood pressure, ideally using
angiotensin-converting enzyme inhibitors or angio-
tensin II receptor blockers.
To help practices achieve the targets measured with
the indicators, the Primary Care Informatics group at
St George’s have created online resources. These
consist of an online calculator to allow glomerular
ﬁltration rate (GFR) to be estimated for individual
patients and a spreadsheet to allow multiple simul-
taneous estimation of GFR. The calculator is also
available in a downloadable format to allow it to be
used on computers not connected to the internet or
with slow connections. The calculator requires the
patient’s age, gender, serum creatinine and race (if
black; Figure 1).
The pilot resources are available at: www.pcel.info/
gfr/ for the online calculator and www.pcel.info/ckd/
for other CKD resources.
The CKD resources include access to the renal
National Service Framework (NSF) guidelines, scien-
tiﬁc papers and other resources. Each resource has
an index card providing further information. The
calculators have been designed to work with standard
UK units and will not accept out-of-range values
(types of data entry error are ﬂagged up in the
spreadsheet). This brief article provides further back-
ground to CKD describes the research we have carried
out, discusses the challenge ofmanaging CKD and sets
out how we might like to see CKD indicators and
targets extended in the future.
The resources include the following calculators
described in more detail in Box 1:
1 an on-line calculator
2 a downloadable version of the on-line calculator
3 mobile phone calculators for the various types of
mobile phone
4 a PDA (personal digital assistant) calculator
5 a spreadsheet for estimating GFR for populations.
Background to CKD
In overview, the management of CKD is about man-
aging cardiovascular risk, with the best evidence being
for controlling hypertension. Primary care colleagues
need to approach cardiovascular risk in CKD just
as they would in a patient with diabetes. Additionally,
practitioners need to consider whether people with
CKD might be on drugs that impair renal function
and additionally, in men, whether they might have
prostatic disease.
Although CKD is a major predictor for end-stage
renal disease (ESRD), death in pre-ESRDpatients with
CKD is predominantly due to cardiovascular disease.2
The prevalence and incidence of cardiovascular disease
are both increased in patients with CKD.3,4 Evidence
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from community based studies demonstrates an in-
verse relationship between renal function and adverse
cardiovascular outcome.5
Managing cardiovascular risk is important in CKD.
Most experts consider a bloodpressure of 130/80mmHg
to be an aspirational target for people with CKD.6,7
However, studies have shown that in people over
65 years and in diabetic patients, this is hard to
achieve.8–11 Some patients have taken four diﬀerent
anti-hypertensive therapies to achieve this target.12
Angiotensin-converting enzyme inhibitors (ACEI)
and angiotensin receptor blockers (ARB) are known
to reduce the rate of deterioration in renal function.13–15
Tighter blood pressure targets remain a goal for future
years of the QOF for CKD.
Reviews suggest that there are growing numbers
of studies that report beneﬁcial eﬀects of statins on
slowing the decline in renal function and on pro-
teinuria.16,17 Cigarette smoking is associated with
an adverse outcome in CKD; a community-based,
Figure 1 Online calculator to estimate GFR
Box 1 Types of on-line calculators to help with estimating eGFR
Calculator type Resource required Notes
On-line Any browser connected to the
internet
Just enter the data requested! N.B. UK units
Downloadable Personal or laptop computer Allows use of the calculator on a PC with no
or limited internet connectivity
Mobile phone Most types of mobile phone Follow the instructions for the diﬀerent types
PDA PDA Sorry, this won’t work on a Palm!
Spreadsheet PC with Microsoft Oﬃce or
Excel
Enable Macros or it won’t calculate! You may
need to change security settings
Help ﬁle is on the second sheet, see ‘Help’ tab
at bottom of sheet.
N.B. The calculators use the four item MDRD equation. This is not validated for children
Lab derived eGFR should always be given priority as the lab calculation takes account of variation in
creatinine measures.
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observational study indicated that 31% of attributable
risk in CKD was due to smoking.18 Consequently,
earlier identiﬁcation of CKD in primary care, better
management of cardiovascular risk, avoiding medi-
cines that impair renal function, considering prostate
disease in men and specialist referral where appropri-
ate, might improve long-term outcomes.
UK general practice research
into undiagnosed CKD
Our investigation of the quality of care in CKD
revealed that this condition was largely undiagnosed,
and that there was scope to improve the management
of cardiovascular co-morbidity and risk with inter-
ventions readily available in primary care.19 CKD is
diagnosed by measuring renal function; one of the
simplest ways of doing this is to estimate GFR from
serum creatinine, age, gender and ethnicity. A GFR of
less than 60 ml/min/1.73 m2 is diagnostic of CKD,
though the diagnosis can still be made with a higher
(and nearer to normal) GFR if there is evidence of
renal damage.
One-quarter of the population (25.7%; 28 862/
112 215) in our 2003 study population had a serum
creatinine recorded in their computer record; this
enabled us to calculate their GFR. One in ﬁve (18.9%)
had aGFR<60ml/min/1.73m2, which is diagnostic of
CKD. This represents 4.9% of the population. Three-
quarters (74.7%; 4075/5449) of those with CKD
had one or more circulatory diseases and risk factors
amenable to intervention in primary care. For example:
the mean systolic blood pressure in those with a
normal GFR was 130mmHg, while for those with a
GFR <60 ml/min/1.73m2 the mean systolic blood
pressure (BP) was 142mmHg. One-way analysis of
variance shows that the diﬀerences were signiﬁcant
at the P<0.001 level. Evidence-based guidance rec-
ommends lowering BP in CKD to 130mmHg.20 There
is considerable scope for intervention and improve-
ment of risk factors. Only 3.6% of these people were
recorded as having renal disease within the GP com-
puter record. A subsequent hand-search of 500 rec-
ords in one practice suggested the computer results
were reliable, with only four more cases having an
indication that they had CKD only in their written
records but not in the computer record.21
The challenge of improving the
management of CKD
Primary care professionals involved in the CKD im-
provement programme had four challenges: GP col-
leagues were often unaware that the prevalence of
CKD was so high (5%); they were not familiar with
the evidence base; the stratiﬁcation of risk took place
outside the computerised medical record using a
method with which they were unfamiliar (i.e. the
estimation of GFR); and they were found lacking
in implementing best practice. Part of the reason we
undertook the hand-search of 500 records was to
generate evidence to overcome the cognitive disson-
ance of GPs that such a large number of people might
have undiagnosed CKD.
Next steps
The starting point for improving quality in CKD is the
identiﬁcation of people with stage 3–5 disease and
improving their BP control. As better evidence be-
comes available wemight wish to addmeasurement of
proteinuria, cholesterol, smoking and anaemia man-
agement to the targets for CKD management. The
National Institute forHealth andClinical Excellence is
due to report on anaemia management in due course.
The estimate of glomerular ﬁltration rate (eGFR)
used in this calculator is the four itemMDRD (modi-
ﬁed diet in renal disease – www.kdoqi....) formula.
This formula which requires age, gender, ethnicity, and
creatinine is validated for adults, but should not be
used in children. Where available laboratory estim-
ated GFR should be given priority over that calculated
using these tools as the laboratory will correct its
creatinine assay to national standards. The MDRD
formula is recommended by the National Service
Framework for Renal Disease.22 In the longer term it
is likely that better formulae will be developed. For the
moment this formula is the best pragmatic choice and
gives clinicians much more information that creatinine
alone.
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